Does empirical Clostridium difficile infection (CDI) therapy result in false-negative CDI diagnostic test results?

Clinical Infectious Diseases

Volumn 57, Issue 4, 2013, Pages 494-500

  Sunkesula, Venkata C K ^a   Kundrapu, Sirisha ^a   Muganda, Christine ^c   Sethi, Ajay K ^c   Donskey, Curtis J ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

CDI; Clostridium difficile; Diagnosis; Empirical treatment

Indexed keywords

GLUTAMATE DEHYDROGENASE; METRONIDAZOLE; VANCOMYCIN; WARFARIN;

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; FALSE NEGATIVE RESULT; FECES ANALYSIS; GEL ELECTROPHORESIS; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; TOXIN ANALYSIS; ULCERATIVE COLITIS;

CDI; CLOSTRIDIUM DIFFICILE; DIAGNOSIS; EMPIRICAL TREATMENT;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; DIAGNOSTIC ERRORS; DIAGNOSTIC TESTS, ROUTINE; FECES; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES;

EID: 84880957004     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit286     Document Type: Article

References (26)

1. Hindle P, Davidson E, Biant LC. Septic arthritis of the knee: the use and effect of antibiotics prior to diagnostic aspiration. Ann R Coll Surg Engl 2012; 94:351-5.
2. Prats E, Dorca J, Pujol M, Garcia L, Barreiro B, et al. Effects of antibiotics on protected specimen brush sampling in ventilator-associated pneumonia. Eur Respir J 2002; 19:944-51.
3. Werner AS, Cobbs CG, Kaye D, Hook EW. Studies on the bacteremia of bacterial endocarditis. JAMA 1967; 202:199-203.
4. Pazin GJ, Saul S, Thompson ME. Blood culture positivity: suppression by outpatient antibiotic therapy in patients with bacterial endocarditis. Arch Intern Med 1982; 142:263-8.
5. Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004; 39:1267-84.
6. Saade E, Deshpande A, Kundrapu S, et al. Appropriateness of empiric therapy in patients with suspected Clostridium difficile infection [published online ahead of print 10 May 2013]. Curr Med Res Opin 2013; doi:10.1185/ 03007995.2013.803956.
7. El-Gammal A, Scotto V, Malik S, et al. Evaluation of the clinical usefulness of C. difficile toxin testing in hospitalized patients with diarrhea. Diagn Microbiol Infect Dis 2000; 36:169-73.
8. Peterson LR, Robicsek A. Does my patient have Clostridium difficile infection? Ann Intern Med 2009; 151:176-9.
9. Guerrero DM, Nerandzic MM, Jury LA, Chang S, Jump RL, Donskey CJ. Clostridium difficile infection in a Department of Veterans Affairs long-term care facility. Infect Control Hosp Epidemiol 2011; 32:513-5.
10. Kundrapu S, Jury LA, Sitzlar BM, Sunkesula VCK, Sethi AK, Donskey CJ. Easily modified factors contribute to delays in diagnosis of Clostridium difficile infection: a cohort study and intervention [published online ahead of print 15 May 2013]. J Clin Microbiol 2013; doi:10.1128/JCM. 03142-12.
11. Scheurer D. Diagnostic and treatment delays in recurrent Clostridium difficile-associated disease. J Hosp Med 2008; 3:156-9.
12. Nerandzic MM, Donskey CJ. Effective and reduced-cost modified selective medium for isolation of Clostridium difficile. J Clin Microbiol 2009; 47:397-400.
13. Kundrapu S, Sunkesula VC, Jury LA, Sethi AK, Donskey CJ. Utility of perirectal swab specimens for diagnosis of Clostridium difficile infection. Clin Infect Dis 2012; 55:1527-30.
14. Miller M, Louie T, Mullane M, et al. Derivation and validation of a simple clinical bedside score (ATLAS) for Clostridium difficile infection which predicts response to therapy. BMC infect Dis 2013; 13:148.
15. Sunkesula VCK, Kundrapu S, Jury LA, Deshpande A, Sethi AK, Donskey CJ. Potential for transmission of spores by patients awaiting laboratory testing to confirm suspected Clostridium difficile infection. Infect Control Hosp Epidemiol 2013; 34:306-8.
16. Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010; 31:431-55.
17. Louie TJ, Cannon K, Byrne B, et al. Fidaxomicin preserves the intestinal microbiome during and after treatment of Clostridium difficile infection (CDI) and reduce both toxin reexpression and recurrence of CDI. Clin Infect Dis 2012; 55:S132-42.
18. Sethi AK, Al-Nassir WN, Nerandzic MM, Bobulsky GS, Donskey CJ. Persistence of skin contamination and environmental shedding of Clostridium difficile during and after treatment of C. difficile infection. Infect Control Hosp Epidemiol 2010; 31:21-27.
19. Jump RL, Pultz MJ, Donskey CJ. Vegetative Clostridium difficile survives in room air on moist surfaces and in gastric contents with reduced acidity: a potential mechanism to explain the association between proton pump inhibitors and C. difficile-associated diarrhea? Antimicrob Agents Chemother 2007; 51:2883-7.
20. Peterson LR, Manson RU, Paule SM, et al. Detection of toxigenic Clostridium difficile in stool samples by real-time polymerase chain reaction for the diagnosis of C. difficile-associated diarrhea. Clin Infect Dis 2007; 45:1152-60.
21. Curry SR, Schlackman JL, Hamilton TM, et al. Perirectal swab surveillance for Clostridium difficile by use of selective broth preamplification and real-time PCR detection of tcdB. J Clin Microbiol 2011; 49: 3788-93.
22. Vardakas KZ, Polyzos KA, Patouni K, Rafailidis PI, Samonis G, Falagas ME. Treatment failure and recurrence of Clostridium difficile infection following treatment with vancomycin or metronidazole: a systematic review of the evidence. Int J Antimicrob Agents 2012; 40: 1-8.
23. Petrella LA, Sambol SP, Cheknis A, et al. Decreased cure and increased recurrence rates for Clostridium difficile infection caused by the epidemic C. difficile BI strain. Clin Infect Dis 2012; 55:351-7.
24. Louie TJ, Miller MA, Crook DW, et al. Effect of age on treatment outcomes in Clostridium difficile infection. J Am Geriatr Soc 2013; 61: 222-30.
25. McFarland LV, Elmer GW, Surawicz CM. Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease. Am J Gastroenterol 2002; 97:1769-75.
26. Al-Nassir WN, Sethi AK, Nerandzic MM, Bobulski GS, Jump RLP, Donskey CJ. Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin. Clin Infect Dis 2008; 47:56-62.